{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:56:53Z","timestamp":1776092213874,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":1905,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000145","name":"Alberta Innovates - Health Solutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000145","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1111\/ajt.14303","type":"journal-article","created":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T02:54:14Z","timestamp":1491620054000},"page":"2474-2480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Posttransplant Lymphoproliferative Disorder After Clinical Islet Transplantation: Report of the First Two Cases"],"prefix":"10.1016","volume":"17","author":[{"given":"A.","family":"Peters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Olateju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Deschenes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.H.","family":"Shankarnarayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.J.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Senior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.14303_bib1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/ajt.12192","article-title":"De novo cancer-related death in Australian liver and cardiothoracic transplant recipients","volume":"13","author":"Na","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14303_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11912-010-0132-1","article-title":"Post-transplantation lymphoproliferative disorders: Diagnosis, prognosis, and current approaches to therapy","volume":"12","author":"Evens","year":"2010","journal-title":"Curr Oncol Rep"},{"key":"10.1111\/ajt.14303_bib3","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues.","year":"2008"},{"key":"10.1111\/ajt.14303_bib4","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/ajt.12196","article-title":"Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders","volume":"13","author":"Morscio","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14303_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: A collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14303_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/01.sla.0000157265.85388.a1","article-title":"2003 report of the intestine transplant registry: A new era has dawned","volume":"241","author":"Grant","year":"2005","journal-title":"Ann Surg"},{"key":"10.1111\/ajt.14303_bib7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/TP.0b013e3181b7509c","article-title":"Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: Improved outcomes with new outlooks","volume":"88","author":"Abu-Elmagd","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14303_bib8","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1600-6143.2011.03896.x","article-title":"Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: Report of the French registry and analysis of subgroups of lymphomas","volume":"12","author":"Caillard","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14303_bib9","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"10.1111\/ajt.14303_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1600-6143.2012.04302.x","article-title":"Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients","volume":"13","author":"Na","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14303_bib11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/bjh.14083","article-title":"Iatrogenic immunosuppression and risk of non-Hodgkin lymphoma in solid organ transplantation: A population-based cohort study in Australia","volume":"174","author":"Na","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1111\/ajt.14303_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1432-2277.2008.00785.x","article-title":"Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance","volume":"22","author":"Abu-Elmagd","year":"2009","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.14303_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.14303_bib14","first-page":"11","article-title":"Clinical pancreatic islet transplantation","volume":"11","author":"Shapiro","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1111\/ajt.14303_bib15","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2337\/dc15-1988","article-title":"Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia","volume":"39","author":"Hering","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1111\/ajt.14303_bib16","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2337\/dc12-0063","article-title":"Improvement in outcomes of clinical islet transplantation: 1999-2010","volume":"35","author":"Barton","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1111\/ajt.14303_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcjd.2012.01.002","article-title":"Islet transplantation at the University of Alberta: Status update and review of progress over the last decade","volume":"36","author":"Senior","year":"2012","journal-title":"Can J Diabetes"},{"key":"10.1111\/ajt.14303_bib18","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1600-6143.2011.03724.x","article-title":"Late cytomegalovirus transmission and impact of T-depletion in clinical islet transplantation","volume":"11","author":"Gala-Lopez","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14303_bib19","unstructured":"Collaborative islet transplant registry [Internet]. [cited 2016 Dec 9] 2016."},{"key":"10.1111\/ajt.14303_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/10428194.2015.1026901","article-title":"Treatment of patients with secondary central nervous system lymphoma with high-dose busulfan\/thiotepa-based conditioning and autologous stem cell transplant","volume":"57","author":"Oh","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/ajt.14303_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/bega.2002.0318","article-title":"Pancreas and islet cell transplantation","volume":"16","author":"Bottino","year":"2002","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1111\/ajt.14303_bib22","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/labinvest.2010.124","article-title":"Quantitative analysis of cell composition and purity of human pancreatic islet preparations","volume":"90","author":"Pisania","year":"2010","journal-title":"Lab Invest"},{"key":"10.1111\/ajt.14303_bib23","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1182\/blood-2008-09-178046","article-title":"Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1111\/ajt.14303_bib24","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1600-6143.2007.01972.x","article-title":"Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab","volume":"7","author":"Kirk","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14303_bib25","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1111\/ajt.13324","article-title":"The impact of EBV status on characteristics and outcomes of posttransplantation lymphoproliferative disorder","volume":"15","author":"Luskin","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14303_bib26","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2009.25.4961","article-title":"Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: Outcomes and prognostic factors in the modern era","volume":"28","author":"Evens","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1111\/ajt.14303_bib27","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1111\/ajt.12990","article-title":"Donor or recipient origin of posttransplant lymphoproliferative disorders following solid organ transplantation","volume":"14","author":"Kinch","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14303_bib28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1470-2045(11)70300-X","article-title":"Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): The prospective international multicentre phase 2 PTLD-1 trial","volume":"13","author":"Trappe","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1111\/ajt.14303_bib29","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1200\/JCO.2016.69.3564","article-title":"Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or R-CHOP consolidation in an international, prospective, multicenter phase II trial","volume":"35","author":"Trappe","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1111\/ajt.14303_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1182\/asheducation-2013.1.95","article-title":"EBV and posttransplantation lymphoproliferative disease: What to do?","volume":"2013","author":"Zimmermann","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/ajt.14303_bib31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2141.2010.08160.x","article-title":"Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines","volume":"149","author":"Parker","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1111\/ajt.14303_bib32","series-title":"Transplant infections.","first-page":"477","article-title":"Epstein-Barr virus infection and lymphoproliferative disorders after transplantation","author":"Preiksaitis","year":"2016"},{"key":"10.1111\/ajt.14303_bib33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3324\/haematol.10595","article-title":"CHOP-21 for the treatment of post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation","volume":"92","author":"Choquet","year":"2007","journal-title":"Haematologica"},{"key":"10.1111\/ajt.14303_bib34","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.hoc.2016.07.004","article-title":"Management of relapsed diffuse large B-cell lymphoma","volume":"30","author":"Crump","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1111\/ajt.14303_bib35","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1200\/JCO.2015.61.1236","article-title":"High doses of antimetabolites followed by high-dose sequential chemoimmunotherapy and autologous stem-cell transplantation in patients with systemic B-cell lymphoma and secondary CNS involvement: Final results of a multicenter phase II trial","volume":"33","author":"Ferreri","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1111\/ajt.14303_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2141.2007.06896.x","article-title":"Efficacy and tolerability of high-dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in children","volume":"140","author":"Taj","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1111\/ajt.14303_bib37","first-page":"765230","article-title":"Treatment of recurrent posttransplant lymphoproliferative disorder of the central nervous system with high-dose methotrexate","volume":"2013","author":"Twist","year":"2013","journal-title":"Case Rep Transplant"},{"key":"10.1111\/ajt.14303_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ajh.20334","article-title":"Mini-BEAM and autologous hematopoietic stem-cell transplant for treatment of post-transplant lymphoproliferative disorders","volume":"79","author":"Komrokji","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1111\/ajt.14303_bib39","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1080\/1042819021000040170","article-title":"Successful treatment of posttransplant lymphoproliferative disorder in a renal transplant patient by autologous peripheral blood stem cell transplantation","volume":"43","author":"Bobey","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/ajt.14303_bib40","first-page":"801082","article-title":"Treatment of recurrent posttransplant lymphoproliferative disorder with autologous blood stem cell transplant","volume":"2015","author":"Malhotra","year":"2015","journal-title":"Case Rep Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.14303","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522251429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522251429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.14303\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:17:45Z","timestamp":1761628665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522251429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1600613522251429"],"URL":"https:\/\/doi.org\/10.1111\/ajt.14303","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Posttransplant Lymphoproliferative Disorder After Clinical Islet Transplantation: Report of the First Two Cases","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.14303","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}